← All organizations

ViraCyte

For profit

Also known as: Legacy Healthcare SA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 1, 2018

Acquired by ElevateBio on May 22, 2019

Timeline

2010s

Jun 1, 2013
ViraCyte— Founded
May 22, 2019
ElevateBio— Acquired By

Drugs by trial phase (5 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

cyclosporine

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Posoleucel

Other trials (1 own, 0 via acquisition)

multivirus specific t cells

Indications

Studied for

Recent trials (7)

NCT03240627Lead sponsorPhase 2/Phase 3Mar 1, 2018
NCT02276820Lead sponsorPhase 1Jun 1, 2017
NCT02313844Lead sponsorPhase 1Jan 1, 2017
NCT02919735Lead sponsorPhase 2Oct 1, 2016
NCT02313857Lead sponsorPhase 1Sep 1, 2015
NCT02108522Lead sponsorN/AJun 1, 2014
NCT01570283Lead sponsorPhase 1/Phase 2Sep 1, 2012

Details

Founded: Houston, TX, US Jun 1, 2013
Last known activity: Mar 1, 2018